Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism
Until recently, the standard treatment of chronic hepatitis C virus (HCV) infection was a combination therapy with PEG-IFN-α plus ribavirin. Previous studies have proven that several markers predict the outcome of such therapy, e.g., pretreatment plasma levels of interferon inducible protein IP-10,...
Saved in:
Main Authors: | Heinz Zoller (Author), Annina Jenal (Author), Albert F. Staettermayer (Author), Sebastian Schroecksnadel (Author), Peter Ferenci (Author), Dietmar Fuchs (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2015-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism
by: Dietmar Fuchs, et al.
Published: (2010) -
Studying the Frequency of Favorable Allele of rs12979860 Polymorphism of IL-28B in Healthy and HCV Infected Iranian Individuals
by: Abdolvahab Alborzi, et al.
Published: (2015) -
Polymorphism of IL-28B Gene (rs12979860) in HCV Genotype 1 Patients Treated by Pegylated Interferon and Ribavirin
by: Fahimeh Safarnezhad Tameshkel, et al.
Published: (2016) -
Tryptophan metabolic pathway and neopterin in asthmatic children in clinical practice
by: Amelia Licari, et al.
Published: (2019) -
EPSTI1 Is Involved in IL-28A-Mediated Inhibition of HCV Infection
by: Xianghe Meng, et al.
Published: (2015)